63.55MMarket Cap-625P/E (TTM)
0.573High0.541Low923.72KVolume0.541Open0.550Pre Close512.51KTurnover2.85%Turnover RatioLossP/E (Static)115.54MShares2.48552wk High0.52P/B17.80MFloat Cap0.51552wk Low--Dividend TTM32.36MShs Float48.960Historical High--Div YieldTTM5.78%Amplitude0.515Historical Low0.554Avg Price1Lot Size
AlloVir Stock Forum
AlloVir and Kalaris Therapeutics Announce Agreement for Transformational Merger to Create Company Focused on Diseases of the Retina
AlloVir has announced a merger with Kalaris Therapeutics in an all-stock transaction. The combined company will focus on developing TH103, a novel anti-VEGF therapy for retinal diseases, invented by Dr. Napoleone Ferrara. After the merger, pre-Merger AlloVir stockholders will own 25.05% and Kalaris stockholders 74.95% of the combined company. ...
Moomoo 24/7· 1 min ago
$Root Inc (ROOT.US)$ $Applied Optoelectronics (AAOI.US)$ $Transcode Therapeutics (RNAZ.US)$ $ShiftPixy (PIXY.US)$ $BranchOut Food (BOF.US)$ $Talaris Therapeutics (TALS.US)$ $Panbela Therapeutics (PBLA.US)$ $AlloVir (ALVR.US)$ $Iveda Solutions (IVDA.US)$ $Locafy (LCFY.US)$
Investment firm Rosenblatt downgraded $Twitter (Delisted) (TWTR.US)$ on Wednesday as the debate surrounding the whistleblower complaint from its former head of security has raised the risks surrounding the stock. Analyst Barton Crockett lowered his rating to neutral from buy and lowered his price target to $37 from $52, noting there are now "meaningful uncertainties" surr...
In reaction to earnings/guidance:
• $Teva Pharmaceutical Industries (TEVA.US)$ +24%(also announces agreement for opioids settlement), $Enphase Energy (ENPH.US)$ +9.5%, $Spotify Technology (SPOT.US)$ +9.2%, $RPC Inc (RES.US)$ +8.5%, $Chipotle Mexican Grill (CMG.US)$ +8.2%, $Manhattan Associates (MANH.US)$ +8.1%, $Hilton Worldwide (HLT.US)$ +6.7%, $ChampionX (CHX.US)$ +6.1%, $Mr. Cooper Group (COOP.US)$ +5.7%, $Constellium (CSTM.US)$ +5.5%, $Boston Scientific (BSX.US)$ +5.4%, ...
No comment yet